Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeutics

2023Biomedicine & PharmacotherapyJournalOpen access

10.1016/j.biopha.2023.115099 Full text18 citations

Authors

8 authors across 5 institutions in 2 countries.

Benjamin Ayodipupo BabalolaFirst authorCorresponding
Oluwamayowa S. Akinsuyi
as printed: Oluwamayowa Samuel Akinsuyi
Elizabeth Oreoluwa Folajimi
- University of Ilorin (NG)
Folakemi Olujimi
- Mountain Top University (NG)
Ahmed Adebisi Otunba
Bruno Chikere
- Covenant University (NG)
Ibitayo Ajayi Adewumagun
- Covenant University (NG)
Tosin Emmanuel AdetobiSenior author
- University of Ilorin (NG)

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

SARS-CoV-2 and COVID-19 Researchlevel 3 · 1.00
CRISPR and Genetic Engineeringlevel 3 · 1.00
SARS-CoV-2 detection and testinglevel 3 · 0.98

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2023 · Biomedicine & Pharmacotherapy · 18 citations
https://openalex.org/W4382777531

Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeutics · Sankore